Product Information
FT ACID REDUCER DR 15 MG CAP is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.4067 per EA under NDC 70677110302. Its NADAC has been published 147 times since Dec 13, 2023.
FDA first approved this application on May 18, 2012.
Strength
15 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677110302
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA202319FDA Approved
5/18/2012
On Market Since
9/14/2023
Pharmacological Classes
Price Statistics
The NADAC for FT ACID REDUCER DR 15 MG CAP has been published 147 times since Dec 13, 2023, and over the history we have for it it has declined 6.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4067 per EA |
|---|---|
| All-time high | $0.4918 (Jul 10, 2024) |
| All-time low | $0.3799 (Dec 20, 2023) |
| 52-week high | $0.4629 |
| 52-week low | $0.4067 |
| Median price | $0.4401 |
| Average price | $0.4413 |
| Largest weekly change | +17.8% (Jun 19, 2024) |
| Weeks tracked | 147 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 64% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lansoprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT ACID REDUCER DR 15 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for FT ACID REDUCER DR 15 MG CAP, manufactured by Strategic Sourcing Services LLC, is $0.4067 per EA (NDC 70677110302), effective Sep 30, 2026.
How has the price of FT ACID REDUCER DR 15 MG CAP changed over time?
Over the history we have for it, the NADAC for FT ACID REDUCER DR 15 MG CAP has declined 6.5%. It has been tracked across 147 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for FT ACID REDUCER DR 15 MG CAP?
Since Dec 13, 2023, the NADAC for FT ACID REDUCER DR 15 MG CAP has ranged from a low of $0.3799 (Dec 20, 2023) to a high of $0.4918 (Jul 10, 2024), with a median of $0.4401 per EA.
Are there cheaper alternatives to FT ACID REDUCER DR 15 MG CAP?
Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LANSOPRAZOLE DR 15 MG CAPSULE, is $0.1474 per EA — about 64% below FT ACID REDUCER DR 15 MG CAP.
Who manufactures FT ACID REDUCER DR 15 MG CAP?
FT ACID REDUCER DR 15 MG CAP (NDC 70677110302) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.